Monday, June 15, 2009

Oncothyreon Hires VP

Seattle-based Oncothyreon reported today that it has hired Dr. Scott Peterson as vice president of research and development, effective Aug. 1. The Seattle-based biotechnology firm said Peterson will oversee its pre-clinical and non-clinical R&D activities in support of oncology product candidates into late-phase clinical trials. Peterson hails from Zymogenetics Inc., where he had served as director and department head of oncology research since 2007. Before that, Oncothyreon noted, Peterson spent eight years at Bothell, Wash.-based ICOS Corp., ultimately rising to principal scientist of oncology drug discovery.